Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of EUR 67.27 billion. The enterprise value is 86.34 billion.

Market Cap	67.27B
Enterprise Value	86.34B

Important Dates

The last earnings date was Wednesday, April 22, 2026.

Earnings Date	Apr 22, 2026
Ex-Dividend Date	Mar 10, 2026

Share Statistics

Current Share Class	217.16M
Shares Outstanding	n/a
Shares Change (YoY)	-3.57%
Shares Change (QoQ)	-0.63%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	96.18%
Float	216.66M

Valuation Ratios

The trailing PE ratio is 14.79 and the forward PE ratio is 14.03.

PE Ratio	14.79
Forward PE	14.03
PS Ratio	0.39
PB Ratio	1.76
P/TBV Ratio	17.36
P/FCF Ratio	12.03
P/OCF Ratio	10.20
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.64, with an EV/FCF ratio of 15.43.

EV / Earnings	18.99
EV / Sales	0.50
EV / EBITDA	11.64
EV / EBIT	12.93
EV / FCF	15.43

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.72.

Current Ratio	1.48
Quick Ratio	1.33
Debt / Equity	0.72
Debt / EBITDA	3.67
Debt / FCF	4.94
Interest Coverage	5.52

Financial Efficiency

Return on equity (ROE) is 12.09% and return on invested capital (ROIC) is 8.63%.

Return on Equity (ROE)	12.09%
Return on Assets (ROA)	3.98%
Return on Invested Capital (ROIC)	8.63%
Return on Capital Employed (ROCE)	9.71%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.80M
Profits Per Employee	47,066
Employee Count	96,615
Asset Turnover	1.63
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 849.95 million in taxes.

Income Tax	849.95M
Effective Tax Rate	15.76%

Stock Price Statistics

The stock price has decreased by -19.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.76%
50-Day Moving Average	266.26
200-Day Moving Average	277.19
Relative Strength Index (RSI)	72.24
Average Volume (20 Days)	4

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.24

Income Statement

In the last 12 months, Elevance Health had revenue of EUR 173.82 billion and earned 4.55 billion in profits. Earnings per share was 20.40.

Revenue	173.82B
Gross Profit	45.00B
Operating Income	6.78B
Pretax Income	5.39B
Net Income	4.55B
EBITDA	7.41B
EBIT	6.78B
Earnings Per Share (EPS)	20.40

Balance Sheet

The company has 32.15 billion in cash and 27.62 billion in debt, giving a net cash position of -19.24 billion.

Cash & Cash Equivalents	32.15B
Total Debt	27.62B
Net Cash	-19.24B
Net Cash Per Share	n/a
Equity (Book Value)	38.20B
Book Value Per Share	175.17
Working Capital	18.84B

Cash Flow

In the last 12 months, operating cash flow was 6.60 billion and capital expenditures -1.00 billion, giving a free cash flow of 5.59 billion.

Operating Cash Flow	6.60B
Capital Expenditures	-1.00B
Depreciation & Amortization	n/a
Net Borrowing	1.57B
Free Cash Flow	5.59B
FCF Per Share	n/a

Margins

Gross margin is 25.89%, with operating and profit margins of 3.90% and 2.62%.

Gross Margin	25.89%
Operating Margin	3.90%
Pretax Margin	3.10%
Profit Margin	2.62%
EBITDA Margin	4.26%
EBIT Margin	3.90%
FCF Margin	3.22%

Dividends & Yields

This stock pays an annual dividend of 5.91, which amounts to a dividend yield of 1.95%.

Dividend Per Share	5.91
Dividend Yield	1.95%
Dividend Growth (YoY)	-3.29%
Years of Dividend Growth	n/a
Payout Ratio	28.97%
Buyback Yield	3.57%
Shareholder Yield	5.52%
Earnings Yield	6.76%
FCF Yield	8.32%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6